High-dose chemotherapy (HDCT) with G-CSF support before radiotherapy (RT) in malignant gliomas (MG):: Phase II trial

被引：0
|
作者：
Viñolas, N
Gil, M
Verger, E
Villá, S
Pujol, T
Caral, L
García, M
Graus, F
Estapé, J
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Inst Catala Oncol, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80869-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
435
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [21] Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas
    K Ogawa
    Y Yoshii
    O Inoue
    T Toita
    A Saito
    Y Kakinohana
    G Adachi
    S Iraha
    W Tamaki
    K Sugimoto
    A Hyodo
    S Murayama
    British Journal of Cancer, 2006, 95 : 862 - 868
  • [22] Mathematical modeling of granulocyte reconstitution after high-dose chemotherapy with stem cell support: effect of post-transplant G-CSF treatment
    Ostby, I
    Kvalheim, G
    Rusten, LS
    Grottum, P
    JOURNAL OF THEORETICAL BIOLOGY, 2004, 231 (01) : 69 - 83
  • [23] Effectiveness of high-dose G-CSF (32 μg/kg) for stem cell mobilization after failure of chemotherapy plus standard dose G-CSF (10 μg/kg) for autologous stem cell transplantation.
    Voralia, M
    Nagy, T
    Trip, K
    Chen, C
    Keating, A
    Crump, M
    BLOOD, 2000, 96 (11) : 178A - 178A
  • [24] ADJUVANT HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF SUPPORT IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER
    KONECNY, G
    UNTCH, M
    BAUERFEIND, I
    PICHE, E
    NESTLEKRAMLING, C
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 79 - 79
  • [25] A randomized trial on the hematological and extra hematological effects of adding GM-CSF to postransplant G-CSF after high-dose chemotherapy with stem cell rescue.
    Murillo, L
    Yubero, A
    Isla, D
    Mayordomo, JI
    Cajal, R
    Palomera, L
    Moreno, JA
    Herráez, J
    Bueso, P
    Martí, JL
    Escudero, P
    Sáenz, A
    García, MD
    Tres, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S97 - S97
  • [26] Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSF
    Jindra, P
    Koza, V
    Lysák, D
    Vozobulová, V
    Steinerová, K
    BONE MARROW TRANSPLANTATION, 2005, 35 (07) : 729 - 730
  • [27] Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSF
    Bone Marrow Transplantation, 2005, 35 : 729 - 730
  • [28] CM-CSF INSTEAD OF HEMATOLOGICAL SUPPORT DURING HIGH-DOSE CHEMOTHERAPY FOR REFRACTORY MALIGNANT-LYMPHOMA
    AVILES, A
    NAMBO, MJ
    TALAVERA, A
    ROSAS, A
    GARCIA, EL
    DIAZMAQUEO, JC
    LEUKEMIA & LYMPHOMA, 1995, 17 (3-4) : 327 - 330
  • [29] PHASE-II STUDY OF AUTOLOGOUS FILGRASTIM (G-CSF)-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS TO RESTORE HEMATOPOIESIS AFTER HIGH-DOSE CHEMOTHERAPY FOR LYMPHOID MALIGNANCIES
    SHERIDAN, WP
    BEGLEY, CG
    TO, LB
    GRIGG, A
    SZER, J
    MAHER, D
    GREEN, MD
    ROWLINGS, PA
    MCGRATH, KM
    CEBON, J
    DYSON, P
    WATSON, D
    BAYLY, J
    DELUCA, E
    TOMITA, D
    HOFFMAN, E
    MORSTYN, G
    JUTTNER, CA
    FOX, RM
    BONE MARROW TRANSPLANTATION, 1994, 14 (01) : 105 - 111
  • [30] Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy
    Lalisang, R. I.
    Erdkamp, F. L. G.
    Rodenburg, C. J.
    Knibbeler-van Rossum, C. T. A. M.
    Nortier, J. W. R.
    van Bochove, A.
    Slee, P. H. Th. J.
    Voest, E. E.
    Wils, J. A.
    Wals, J.
    Loosveld, O. J. L.
    Smals, A. E. M.
    Blijham, G. H.
    Tjan-Heijnen, V. C. G.
    Schouten, H. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (02) : 437 - 445
12345